The Children's Mercy oncology program is a national leader in cancer treatment. Our program provides pediatric patients with comprehensive clinical services and innovative treatment—including Phase I Experimental Therapeutics, stem cell transplantation, and immunotherapies such as CAR T-cell—supported by the latest research.
We provide advanced treatment for children with cancer including brain tumors, leukemia, lymphoma, solid tumors—including Neuroblastoma, Wilms, Liver, Germ Cell, etc.,—bone and soft tissue tumors, histiocytic diseases, and vascular tumors.
Care is offered in Kansas City and regionally in Joplin and Springfield, Mo. Our Spanish-speaking clinic is available in Kansas City.
Pediatric oncologists and specialists
Our care team includes more than 25 pediatric oncologists and hematology specialists. Dedicated nurse practitioners help coordinate each step of treatment. This includes chemotherapy, surgery, radiation, labs, and any other services patients and families need from the time of diagnosis until care is completed. Our team creates a care plan suited to each child's individual treatment needs.
Designated by the National Institutes of Cancer
As the primary pediatric cancer provider and the only NCI Children’s Oncology Group institution in the Midwest Cancer Alliance, Children’s Mercy is the pediatric consortium partner for the National Cancer Institute-designated The University of Kansas Cancer Center and the Stowers Institute for Medical Research. This partnership offers progress in cutting-edge cancer research to help the plight of children with cancer.
The Division also has received accreditation from the Foundation for Accreditation of Cellular Therapy.